These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15199742)

  • 1. [Molecular mechanisms of thrombogenesis and vascular pathologies in vivo].
    Yamamoto K
    Rinsho Ketsueki; 2004 May; 45(5):347-54. PubMed ID: 15199742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thromboresistance of vascular wall, atherogenesis, and humoral factors of thrombogenesis].
    Barkagan ES; Eremin GF
    Ter Arkh; 1981; 53(9):71-8. PubMed ID: 7302863
    [No Abstract]   [Full Text] [Related]  

  • 3. [The paradox of hemostasis in the centenarian].
    Quéré I; Gris JC; Janbon C
    J Mal Vasc; 2002 Jul; 27 Spec No():S30-3. PubMed ID: 12587218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular regulation of plasminogen activator inhibitor-1 activity.
    Edelberg JM; Sane DC; Pizzo SV
    Semin Thromb Hemost; 1994; 20(4):319-23. PubMed ID: 7899861
    [No Abstract]   [Full Text] [Related]  

  • 5. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.
    Yamamoto K; Takeshita K; Kojima T; Takamatsu J; Saito H
    Cardiovasc Res; 2005 May; 66(2):276-85. PubMed ID: 15820196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of coagulation factors on experimental thrombogenesis and their changes after thrombosis.
    Marbet GA; Duckert F
    Thromb Diath Haemorrh; 1973 Jun; 29(3):619-32. PubMed ID: 4761830
    [No Abstract]   [Full Text] [Related]  

  • 7. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.
    Agirbasli M
    Int J Clin Pract; 2005 Jan; 59(1):102-6. PubMed ID: 15707473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Angiokinase"--molecular weights of proteins representing a perivascular plasminogen activator.
    Auerswald W; Binder B; Doleschel W
    Thromb Diath Haemorrh; 1971 Oct; 26(2):411-3. PubMed ID: 5134490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombosis and fibrinolysis].
    Tanaka K
    Rinsho Byori; 1969; 16():Suppl 16:10+. PubMed ID: 4903819
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated intravascular coagulation: What's new?
    Levi M
    Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of thrombogenesis].
    Sueishi K
    Nihon Rinsho; 1989 Apr; 47(4):870-5. PubMed ID: 2746891
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis.
    Izuhara Y; Takahashi S; Nangaku M; Takizawa S; Ishida H; Kurokawa K; van Ypersele de Strihou C; Hirayama N; Miyata T
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):672-7. PubMed ID: 18239154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome, haemostasis and thrombosis.
    Alessi MC; Juhan-Vague I
    Thromb Haemost; 2008 Jun; 99(6):995-1000. PubMed ID: 18521499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
    Hennan JK; Elokdah H; Leal M; Ji A; Friedrichs GS; Morgan GA; Swillo RE; Antrilli TM; Hreha A; Crandall DL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombogenesis.
    Deykin D
    N Engl J Med; 1967 Mar; 276(11):622-8. PubMed ID: 6018451
    [No Abstract]   [Full Text] [Related]  

  • 19. The vascular wall in the pathogenesis of thrombosis.
    Spaet TH; Erichson RB
    Thromb Diath Haemorrh Suppl; 1966; 21():67-86. PubMed ID: 5339028
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia--effects of selective inducible nitric oxide synthase inhibition.
    Matejovic M; Krouzecky A; Radej J; Rokyta R; Kralova H; Radermacher P; Novak I
    Thromb Haemost; 2007 Feb; 97(2):304-9. PubMed ID: 17264961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.